Bivirkninger, der er rapporteret i kliniske undersøgelser eller efter markedsføring hos patienter behandlet med interferon alfa- 2b, inklusive PegIntron monoterapi eller PegIntron + ribavirin.
Adverse reactions reported in clinical trials or through post-marketing surveillance in patients treated with interferon alfa-2b, including PegIntron monotherapy or PegIntron + ribavirin.